User reviews indicate that Mitolyn does not provide an immediate "rush” of energy. Instead, the effects gradually build over ...

Antengene Corporation Limited ('Antengene', SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical ...

UK Government's chief scientific adviser says unlimited blood supplies could be grown from stem cells and end surgery and ...

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments.

Synthetic Design Lab Inc., which emerged from stealth with a $20 million seed round and a platform technology aimed at advancing the antibody-drug conjugate (ADC) space, began with its founders ...

Known as CPMAC, the molecule's inclusion in perovskite solar cells delivers a power conversion efficiency of 26%.

Charity Killing Cancer Kindly says synthetic these pills 'bombard the body with huge doses of wholly unnecessary nutrients' ...

Press Release Grove Biopharma, a private biotechnology company pioneering its Bionic Biologics™ platform to develop therapies targeting previously intractable intracellular disease targets, today ...

The US Food and Drug Administration plans to phase out the use of petroleum-based synthetic dyes in the US food supply due to ...

Organoids and synthetic embryos mark a pivotal shift in biomedical research, highlighting the need for ethical oversight amid ...

Boehringer Ingelheim has slipped another piece of its oncology R&D strategy into place, partnering with Tessellate Bio on a ...

Synthetic Design Lab, a next-generation antibody-drug conjugate (ADC) company advancing its novel SYNTHBODY therapeutic ...